Figure 2.
Urine exosomal PCA3/PRAC predicts the biopsy outcome. For each cohort, ROC curve analysis is performed for (a) any-grade and (b) high-grade prostate cancer to determine the AUC for LBXexo, PCA3 alone, and PSA test, respectively. ROC, receiver-operating characteristic; AUC, area under the curve.